Stockreport

NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026

Neuropace, Inc.  (NPCE) 
PDF MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, to [Read more]